top of page
3D-TRUBI Device

Innovative Diagnostic Solutions to Increase
Medical Readiness

Bring the power of point-of-injury imaging to your patients 

Point of Care Diagnosis

3D Imaging of Intracranial Hemorrhages

Ruggedized, Portable and Lightweight

Easy-to-use and User-friendly

Meet 3D-TRUBI
3D Tr
anscranial Ultrasound Brain Imaging

3D-TRUBI is an easy-to-use, ruggedized, portable, lightweight, shock and impact resistant device suitable for use in austere combat and civilian environments by medical personnel with all levels of training.

3D Imaging of intracranial hemorrhages and determining their types

Point-of-Injury (POI) / Point-of-Initial-Care (POIC) diagnostic imaging

3D-TRUBI Device x860.png

Ruggedized, Portable, Lightweight, Shock and Impact Resistant

Short learning curve, Easy-to-use and User-friendly

TRUBI-GUI-monitor.png

Our Technology

As a spin-off from Tessonics Corporation, TMS currently focuses on further development and commercialization of the 3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) technology that has been originally developed by Tessonics Corporation during the past decade. TMS aims to implement the 3D-TRUBI technology in an advanced ultrasound diagnostic imaging instrument that will provide a forward-deployable solution for rapid and accurate diagnosis of life-threatening traumatic brain injuries (TBI).

3D-TRUBI in Action

Below images and animation shows the effectiveness of 3D-TRUBI for primary and differential diagnosis of Intracranial Hematomas (ICT)

Type 1:
Epidural Hematoma

Type 2:
Subdural Hematoma

Type 3:
Intracerebral Hematoma

Our Story

Tessonics Medical Systems Inc. (TMS) was founded in Birmingham, MI, USA, in 2019. TMS focuses on developing innovative diagnostic instrumentation solutions to enhance medical readiness, reduce fatalities, optimally treat life-threatening injuries, and promote positive long-term outcomes.

 

The primary focus of TMS is to further develop and commercialize the 3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) technology pioneered by Tessonics Corporation over the past decade. This endeavor has also been supported by an award from the Office of the Assistant Secretary of Defense for Health Affairs (OASDHA).*

TMS aims to implement the 3D-TRUBI technology in an advanced ultrasound diagnostic imaging instrument that will provide a forward-deployable solution for rapid and accurate diagnosis of life-threatening brain hemorrhages associated with traumatic brain injuries (TBI). 3D-TRUBI is preparing for Phase I clinical studies in Q3 2024, with funding approved at the Brooke Army Medical Center in San Antonio, TX.**

 

*Combat Readiness – Medical Research Program – Rapid Development and Translational Research Award No. W81XWH-20-1-0852.

**Military Traumatic Brain Injury Initiative (MTBI2) – Uniformed Services University of the Health Sciences

Tessonics Medical BG - 35.png

Get in Touch

We would like to hear from you!

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Thanks for submitting!

bottom of page